ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 164 filers reported holding ACCELERON PHARMA INC in Q4 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $847,624,000 | +37.6% | 4,925,189 | +0.3% | 0.02% | +40.0% |
| Q2 2021 | $616,201,000 | -10.5% | 4,910,353 | -3.3% | 0.02% | -21.1% |
| Q1 2021 | $688,451,000 | +7.0% | 5,076,695 | +1.0% | 0.02% | 0.0% |
| Q4 2020 | $643,357,000 | +21.7% | 5,028,578 | +7.0% | 0.02% | +11.8% |
| Q3 2020 | $528,689,000 | +28.0% | 4,698,201 | +8.4% | 0.02% | +13.3% |
| Q2 2020 | $412,930,000 | +7.8% | 4,334,313 | +1.7% | 0.02% | -6.2% |
| Q1 2020 | $382,951,000 | +73.4% | 4,261,168 | +2.3% | 0.02% | +100.0% |
| Q4 2019 | $220,836,000 | +33.9% | 4,165,147 | -0.2% | 0.01% | +33.3% |
| Q3 2019 | $164,975,000 | -1.7% | 4,175,521 | +2.2% | 0.01% | 0.0% |
| Q2 2019 | $167,881,000 | -10.1% | 4,086,713 | +1.9% | 0.01% | -14.3% |
| Q1 2019 | $186,803,000 | +21.8% | 4,011,248 | +13.9% | 0.01% | 0.0% |
| Q4 2018 | $153,411,000 | -21.7% | 3,522,628 | +2.8% | 0.01% | -12.5% |
| Q3 2018 | $196,034,000 | +56.9% | 3,425,363 | +33.0% | 0.01% | +60.0% |
| Q2 2018 | $124,976,000 | +27.9% | 2,575,755 | +3.1% | 0.01% | +25.0% |
| Q1 2018 | $97,715,000 | -5.6% | 2,499,098 | +2.5% | 0.00% | -20.0% |
| Q4 2017 | $103,484,000 | +19.0% | 2,438,378 | +4.6% | 0.01% | +25.0% |
| Q3 2017 | $86,958,000 | +41.0% | 2,330,048 | +14.8% | 0.00% | +33.3% |
| Q2 2017 | $61,663,000 | +21.8% | 2,029,040 | +6.1% | 0.00% | 0.0% |
| Q1 2017 | $50,619,000 | +13.1% | 1,912,335 | +9.1% | 0.00% | +50.0% |
| Q4 2016 | $44,753,000 | -26.6% | 1,753,621 | +4.1% | 0.00% | -50.0% |
| Q3 2016 | $60,954,000 | +9.0% | 1,684,253 | +2.3% | 0.00% | +33.3% |
| Q2 2016 | $55,939,000 | +44.7% | 1,646,234 | +12.4% | 0.00% | 0.0% |
| Q1 2016 | $38,659,000 | -37.3% | 1,464,859 | +15.9% | 0.00% | -25.0% |
| Q4 2015 | $61,651,000 | -82.1% | 1,264,386 | -86.7% | 0.00% | -69.2% |
| Q3 2015 | $344,184,000 | +1159.7% | 9,495,525 | +999.7% | 0.01% | +550.0% |
| Q2 2015 | $27,322,000 | -9.2% | 863,497 | +9.3% | 0.00% | 0.0% |
| Q1 2015 | $30,082,000 | -0.4% | 790,376 | +2.0% | 0.00% | 0.0% |
| Q4 2014 | $30,189,000 | +35.8% | 774,869 | +5.4% | 0.00% | 0.0% |
| Q3 2014 | $22,236,000 | -4.7% | 735,327 | +7.1% | 0.00% | 0.0% |
| Q2 2014 | $23,322,000 | +74.8% | 686,528 | +77.5% | 0.00% | +100.0% |
| Q1 2014 | $13,342,000 | +153.0% | 386,708 | +190.4% | 0.00% | – |
| Q4 2013 | $5,274,000 | – | 133,176 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |